Trial NCT03592407

View at ClinicalTrials.gov 
Org. Study IDs: 17302
Secondary IDs: 17302 NCI-2018-00682

Last trial update was posted on 2022-03-08

MeSH Interventions

Pembrolizumab

MeSH Conditions

Adenocarcinoma Esophageal Squamous Cell Carcinoma

Other Conditions

Esophageal Adenocarcinoma Gastroesophageal Junction Adenocarcinoma

Stopping Reasons

Safety concerns

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID